imatinib mesylate has been researched along with Adnexal Diseases in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Durie, N; Kesterson, J; Lele, S; Mhawech-Fauceglia, P; Syriac, S | 1 |
1 other study(ies) available for imatinib mesylate and Adnexal Diseases
Article | Year |
---|---|
Female adnexal tumor of probable Wolffian origin (FATWO) with recurrence 3 years postsurgery.
Topics: Adenoma; Adnexal Diseases; Adult; Antineoplastic Agents; Benzamides; Biomarkers, Tumor; Breast Neoplasms; Broad Ligament; Female; Humans; Imatinib Mesylate; Immunohistochemistry; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Ovarian Neoplasms; Piperazines; Polymerase Chain Reaction; Pyrimidines; Selective Estrogen Receptor Modulators; Tamoxifen | 2011 |